最新ニュース Signify (OTC:PHPPY) 株価情報

Signify NV is a lighting solutions provider based in the Netherlands. Its product portfolio includes luminaires, lamps, LED lamps, LED tubes, and decorative lighting. The company operates through three segments, with the Digital Solutions segment being the largest. Signify generates most of its revenues from this segment and operates mainly in Europe, the Americas, and other international markets.

Signify NV

<a href="https://www.federalreserve.gov/aboutthefed/boardmeetings/files/leverage-ratio-memo-20250625.pdf">https://www.federalreserve.gov/aboutthefed/boardmeetings/files/leverage-ratio-memo-20250625.pdf</a>

Macro Notification

News

Economics

General

US Federal Reserve Proposes Changes To Ease Enhanced Supplementary Leverage Ratio For Large Banks;  Fed Proposal Would Reduce Aggregate Tier 1 CapitalRequirements For Global Systemically Important Banks By 1.4% Or $13B ; Proposal Would Reduce Capital Requirements For Depository Institution Subsidiaries Of Global Banks By 27% Or $213B

WIIM

ICCC

ImmuCell shares are trading lower. The company announced it will commence a CEO and president succession plan amid its current CEO's plan to retire in 2026.

<a href="https://www.bloomberg.com/news/articles/2025-06-25/nike-air-max-phenomena-is-joining-snoafer-trend">https://www.bloomberg.com/news/articles/2025-06-25/nike-air-max-phenomena-is-joining-snoafer-trend</a>

'Nike's Snoafer Listed for $500 Before It's Even Released'- Bloomberg

The Metals Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) stock is trading higher Wednesday after Wedbush upgraded the stock from a Neutral rating to an Outperform rating and raised its <a href="https://www.benzinga.com/quote/TMC/analyst-ratings">price target from $6 to $11</a>.
What To Know: Wedbush has &#8220;significantly increased confidence&#8221; in the company&#8217;s longer-term growth potential after President Donald Trump signed an Executive Order supporting critical mineral development at the end of April.
Trump's April 24 executive order directs federal agencies to fast-track permits for seabed mining of critical minerals like nickel, cobalt and rare earths. Overall, it aims to boost domestic processing, encourage the use of U.S. ships and reduce reliance on foreign supply chains, specifically related to China.
The Metals Company is <a href="https://miningdigital.com/operations/the-metals-company-sweeping-sea-bed-for-battery-materials">developing</a> deep-sea mining technology to extract battery metals from the ocean floor, making it a potential beneficiary of the policy shift toward domestic seabed resource development.
How To Buy TMC Stock
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in The Metals Company&#8217;s case, it is in the Materials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
See Also: <a href="https://www.benzinga.com/news/contracts/25/06/46099576/saic-lands-nearly-1-billion-contract-to-modernize-us-air-force">SAIC Lands Nearly $1 Billion Contract To Modernize US Air Force</a>
TMC Price Action: At the time of writing, The Metals Company shares are trading 16.8% higher at $7.72, according to data from <a href="https://www.google.com/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https://www.benzinga.com/pro/&amp;ved=2ahUKEwjupI_VgI2OAxUmKVkFHYQgE_MQFnoECCAQAQ&amp;usg=AOvVaw0xIsPvjIcIIsWev01-6zR2">Benzinga Pro</a>.
Photo: courtesy of The Metals Company.

The Metals Company (TMC) Stock Is Climbing Wednesday: What's Going On?

Ferric's ultra-compact IVRs for Marvell integrated power solutions to boost performance, efficiency and ROI of accelerated infrastructure
Ferric, Inc., a leader in cutting-edge power conversion solutions, announced its collaboration with Marvell Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) to develop optimized integrated power solutions for Marvell&#xAE; custom silicon platforms, designed to improve performance, efficiency and return on investment (ROI) for AI and cloud infrastructure.
Ferric's proprietary thin-film magnetic technology enables the world's highest density DC-DC power converters and marks a breakthrough in integrated power management. By miniaturizing power regulation at the silicon level, Ferric Integrated Voltage Regulators (IVRs) are more than 10x smaller than conventional solutions— making them uniquely suited for in-package integration in advanced processors. This compact form allows power to be delivered with minimal distance and loss, unlocking unprecedented efficiency, speed and scalability.

MRVL

Ferric Collaborates With Marvell Technology To Develop Optimized Integrated Power Solutions For Marvell Custom Silicon Platforms

Goldman Sachs analyst Kate McShane maintains Five Below (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) with a Buy and raises the price target from $122 to $135.

Price Target

Analyst Ratings

FIVE

Goldman Sachs Maintains Buy on Five Below, Raises Price Target to $135

ARAI

Arrive AI shares are trading higher. The company may be moving on continued strength after the company announced on Tuesday that it will team up with India's Skye Air to expand its drove delivery system with smart mailboxes.

<a href="https://www.marijuanamoment.net/house-votes-to-let-va-doctors-recommend-medical-marijuana-to-military-veterans-and-to-support-psychedelics-research/" title="https://www.marijuanamoment.net/house-votes-to-let-va-doctors-recommend-medical-marijuana-to-military-veterans-and-to-support-psychedelics-research/">https://www.marijuanamoment.net/house-votes-to-let-va-doctors-recommend-medical-marijuana-to-military-veterans-and-to-support-psychedelics-research/</a>
<a href="https://www.marijuanamoment.net/house-votes-to-let-va-doctors-recommend-medical-marijuana-to-military-veterans-and-to-support-psychedelics-research/">https://www.marijuanamoment.net/house-votes-to-let-va-doctors-recommend-medical-marijuana-to-military-veterans-and-to-support-psychedelics-research/</a>

AKAN

ATAI

CMPS

CRON

CYBN

DRUG

ENVB

GHRS

GRWG

IMCC

MNMD

MSOS

SNDL

TLRY

'House Votes To Let VA Doctors Recommend Medical Marijuana To Military Veterans And To Support Psychedelics Research' - Marijuana Moment

Goldman Sachs analyst Paul Choi maintains Amarin Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRN#NASDAQ">AMRN</a>) with a Sell and raises the price target from $7 to $12.

AMRN

Goldman Sachs Maintains Sell on Amarin Corp, Raises Price Target to $12

Nektar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTR#NASDAQ">NKTR</a>) released on Tuesday statistically significant data from the 16-week induction period of the ongoing Phase 2b REZOLVE-AD <a href="https://www.benzinga.com/news/health-care/25/06/46074205/nektar-therapeutics-shares-double-on-promising-eczema-drug-data" target="_blank" rel="noreferrer noopener">study of investigational rezpegaldesleukin</a>.
The trial met its primary endpoint of the <a href="https://www.benzinga.com/general/health-care" target="_blank" rel="noreferrer noopener">mean improvement in Eczema</a> Area and Severity Score (EASI) from baseline at week 16 for all three dose arms of rezpegaldesleukin versus placebo.
All three dose arms also achieved statistical significance at week 16 for the key secondary endpoints of EASI-75 (percent of patients who achieve ≥75% reduction in EASI from baseline), EASI-50 (percent of patients who achieve ≥50% reduction in EASI from baseline) and BSA (mean percent improvement in Body Surface Area score from baseline).
Also Read: <a href="https://www.benzinga.com/news/health-care/25/06/46074205/nektar-therapeutics-shares-double-on-promising-eczema-drug-data" target="_blank" rel="noreferrer noopener">Nektar Therapeutics Shares Double On Promising Eczema Drug Data</a>
After 16 weeks, patients had a 53% to 61% improvement in symptoms. This was compared to a 31% improvement for the placebo group.
William Blair writes, &#8220;We believe the efficacy parameters of rezpeg appear to be comparable to the OX40 drug class though numerically lower than Dupixent across the Phase IIb programs.&#8221;
Given the chronic nature of atopic dermatitis, analyst Andy Hsieh wrote that the high frequencies (high 30% to high 40% across a broader set of rezpeg safety data that includes the Phase 2b results) of injection site reactions versus Regeneron Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>)/Sanofi SA&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) Dupixent (in the high-single- to mid-double-digit percent range) could be a commercial liability for rezpeg.
If rezpeg indeed demonstrates a remittive effect, it could mitigate injection site reactions, though investors will have to wait until the next update (Phase IIb REZOLVE-AD maintenance data) in early 2026 or 52-week off-treatment results in 2027.
The analyst adds, &#8220;Since we believe there is an absence of clear differentiation in the highly competitive atopic dermatitis field, we view today's stock reaction (up roughly 135%) as a valuation normalization event and not a reflection of investors ascribing value to a differentiated asset. Essentially, Nektar shares now trade around the company's current cash levels. We await further updates to gain appreciation of rezpeg&#8217;s potential remittive effect, which could elevate the asset against competitive offerings.&#8221;
NKTR Price Action: Nektar Therapeutics stock is up 26.83% at $31.01 at publication on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46097909/robinhood-ceo-highlights-retail-investor-interest-in-nvidia-tesla-despite-middle-east-tensions-barely-a-blip" target="_blank" rel="noreferrer noopener">Robinhood CEO Highlights Retail Investor Interest In Nvidia, Tesla Despite Middle East Tensions: &#8216;Barely A Blip&#8217;</a></li>
</ul>

Analyst Color

Biotech

Health Care

Movers

Trading Ideas

NKTR

REGN

Why Is Nektar Therapeutics Stock Trading Higher On Wednesday?

BlackBerry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) shares experienced a significant surge on Wednesday after the company reported better-than-expected first-quarter financial results and raised its fiscal 2026 sales guidance on Tuesday.
BlackBerry reported <a target="_blank" href="https://www.benzinga.com/markets/earnings/25/06/46084802/blackberry-stock-climbs-after-better-than-expected-q1-report-details" rel="noreferrer noopener">quarterly earnings of</a> two cents per share, which beat the analyst consensus estimate of&nbsp;zero cents. Quarterly revenue of $121.7 million&nbsp;beat the Street estimate of&nbsp;$112.18 million.
QNX revenue increased 8% to $57.5 million, while Secure Communications&#8217; revenue exceeded previously provided guidance at $59.5 million.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44633991/blackberrys-qnx-secure-comms-growth-weighed-down-by-tariff-uncertainties-government-election-shifts-analyst" rel="noreferrer noopener">BlackBerry&#8217;s QNX, Secure Comms Growth Weighed Down By Tariff Uncertainties, Government Election Shifts: Analyst</a>
BlackBerry affirmed its fiscal 2026 adjusted EPS guidance of 8 cents to 10 cents. The company raised its fiscal 2026 revenue guidance from $504 million-$534 million&nbsp;to $508 million-$538 million versus the $513.51 million&nbsp;estimate.
Following the strong results, Wall Street analysts re-evaluated their positions and raised their price forecasts for BlackBerry.
RBC Capital analyst Paul Treiber maintained a <a target="_blank" href="https://www.benzinga.com/quote/BB/analyst-ratings" rel="noreferrer noopener">Sector Perform rating</a> on BlackBerry while slightly increasing his price forecast from $3.75 to $4.
Treiber&#8217;s assessment highlighted that BlackBerry&#8217;s first-quarter results surpassed both RBC&#8217;s and consensus estimates, primarily due to stronger-than-expected revenue from the Secure Communications and QNX segments.
However, he noted that the company&#8217;s slightly raised fiscal 2026 guidance remains conservative, as it still anticipates an uncertain automotive and broader macro-environment.
Despite experiencing healthy pipeline growth, Treiber emphasized that visibility into auto production remains low, and new deals might face delays.
Canaccord Genuity analyst Kingsley Crane maintained a Hold rating on BlackBerry shares while modestly increasing the price forecast from $4.25 to $4.60.
BlackBerry reported first-quarter results meaningfully ahead of Crane&#8217;s expectations, highlighted by strong IoT or QNX results, which continues to be the standout leader within the business.
The analyst noted that Secure Communications turned in a solid performance amidst a challenging backdrop, driven by ongoing headwinds in the UEM portion of the business.
He said that Unified Endpoint Management (UEM) revenue grew sequentially in the fourth quarter, but challenges in the segment were cited to have affected the decline in ARR.
As Crane looks ahead to the remainder of the calendar year 2025, he sees a distinctly improved outlook for BlackBerry&#8217;s business compared to the previous year.
The analyst noted that strategic initiatives will be incrementally streamlined, and meaningfully positive adjusted EBITDA creates new organic and inorganic investment opportunities.
A ~$865 million QNX backlog offers significant revenue opportunities in the coming years. However, Crane, while acknowledging this significant opportunity, expressed a need for greater clarity on the precise timing and pace at which this backlog will translate into a substantial acceleration, or &#8220;inflection,&#8221; in IoT (Internet of Things) growth.
This visibility challenge is further exacerbated by ongoing uncertainties surrounding auto tariffs. These tariffs can disrupt automotive production volumes, potentially delaying the conversion of QNX backlog into recognized revenue, even though the contracts themselves remain intact.
Crane said management&#8217;s tone has improved considerably in one quarter, but fiscal guidance raised by less than the in-quarter beat ultimately reflects ongoing prudence as the company navigates a dynamic macroeconomic environment.
The analyst noted that less than half of BlackBerry&#8217;s QNX revenue was driven by North America in fiscal 2025, as well as a budding general embedded opportunity (medical, industrial automation, robotics), which represented 18% of QNX revenue in fiscal 2025.
Looking ahead, the general embedded opportunity is poised for substantial expansion, representing a considerable 43% of the overall pipeline for SDV (Software-Defined Vehicle) 8.0.
This strong pipeline suggests that BlackBerry is strategically positioned to make more material sales and marketing investments to accelerate conversions and capitalize on these promising non-automotive end markets.
Price Action: BB stock is trading higher by 15.5% to $5.00 at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/reiteration/25/06/46078928/apple-may-finally-catch-up-in-ai-analyst-sees-big-upside-from-perplexity-deal-smarter-siri-google-search-rivalry" target="_blank" rel="noreferrer noopener">Apple May Finally Catch Up In AI: Analyst Sees Big Upside From Perplexity Deal, Smarter Siri, Google Search Rivalry</a></li>
</ul>
Photo by Michael Vi via Shutterstock

Reiteration

Tech

This Isn't Your Father's BlackBerry, And Its Comeback Is Gaining Traction

CBIO

Crescent Biopharma shares are trading higher after Stifel initiated coverage on the stock with a Buy rating and announced a price target of $28.

Senator Cynthia Lummis (R-Wyo.) has expressed optimism that the White House is actively supportive of passing major <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46067898/trumps-crypto-ventures-have-been-lucrative-but-adam-schiff-says-he-is-bringing-in-a-law-to-end-corruption-in-plain-sight">crypto legislation as soon as July</a>.
What Happened: In a June 25 <a href="https://x.com/Cointelegraph/status/1937875255281996181">interview</a> on CNBC&#8217;s Squawk Box, Lummis pointed to the GENIUS Act, a stablecoin-focused bill passed by the Senate last week, as evidence of this momentum.
"The White House is ahead of us. They&#8217;ve already passed the GENIUS Act," Lummis said, referring to the administration's apparent readiness to push forward with crypto regulation.
She emphasized that stablecoin legislation needs to advance this year and believes there is strong executive branch enthusiasm for seeing Congress deliver a win on the issue.
"There's real excitement at the White House to see Congress send them something they can sign, specially around stablecoins," she said. "The GENIUS Act is a high-quality bill. I believe it's worthy of the president's signature."
Also Read: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46055637/fiserv-paypal-expand-partnership-to-advance-stablecoin-payments">Fiserv, PayPal Expand Partnership To Advance Stablecoin Payments</a>
Why It Matters: The GENIUS Act lays the groundwork for a federal regulatory framework for U.S. dollar-pegged stablecoins, establishing rules for issuance, reserve backing, and consumer protection. While the Senate has passed the bill in the last week, it still awaits a vote in the House, which may not take immediate action.
Despite the delay, key Senate Republicans have urged swift adoption, hoping the bill will become law by July 4. Lummis praised the bill's structure, saying it: preserves the dual banking system, protects consumers and secures financial future.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45989307/senate-passes-genius-act-coinbases-brian-armstrong-calls-it-big-milestone-scott-bessent-says-passage-could-drive-stablecoins-into-a-3-7-trillion-market">Senate Passes GENIUS Act—Coinbase&#8217;s Brian Armstrong Calls It &#8216;Big Milestone,&#8217; Scott Bessent Says Passage Could Drive Stablecoins Into A $3.7 Trillion Market</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

'Bitcoin Senator' Cynthia Lummis Lauds White House's 'Real Enthusiasm' For Crypto Legislation

REAX

Real Brokerage shares are trading higher after B. Riley Securities initiated coverage on the stock with a Buy rating and announced a price target of $7.

SRPT

Sarepta Therapeutics shares are trading lower after HC Wainwright & Co. downgraded the stock from Neutral to Sell and cut its price target on the stock from $40 to $10.

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Health Care sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GILD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/27/25</td>
<td>$103.00</td>
<td>$76.5K</td>
<td>1.3K</td>
<td>6.0K</td>
</tr>
<tr>
<td>VRNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$110.00</td>
<td>$98.1K</td>
<td>12</td>
<td>1.0K</td>
</tr>
<tr>
<td>HIMS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$30.00</td>
<td>$28.4K</td>
<td>4.0K</td>
<td>707</td>
</tr>
<tr>
<td>SMLR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$40.00</td>
<td>$25.8K</td>
<td>161</td>
<td>657</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding GILD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>), we observe a put option sweep with bearish sentiment. It expires in 2 day(s) on June 27, 2025. Parties traded 494 contract(s) at a $103.00 strike. This particular put needed to be split into 40 different trades to become filled. The total cost received by the writing party (or parties) was $76.5K, with a price of $155.0 per contract. There were 1365 open contracts at this strike prior to today, and today 6023 contract(s) were bought and sold. 
• Regarding VRNA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNA#NASDAQ">VRNA</a>), we observe a call option sweep with bearish sentiment. It expires in 51 day(s) on August 15, 2025. Parties traded 249 contract(s) at a $110.00 strike. This particular call needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $98.1K, with a price of $389.0 per contract. There were 12 open contracts at this strike prior to today, and today 1001 contract(s) were bought and sold. 
• Regarding HIMS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>), we observe a put option sweep with bullish sentiment. It expires in 51 day(s) on August 15, 2025. Parties traded 200 contract(s) at a $30.00 strike. This particular put needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $28.4K, with a price of $142.0 per contract. There were 4078 open contracts at this strike prior to today, and today 707 contract(s) were bought and sold. 
• Regarding SMLR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMLR#NASDAQ">SMLR</a>), we observe a call option sweep with neutral sentiment. It expires in 86 day(s) on September 19, 2025. Parties traded 34 contract(s) at a $40.00 strike. This particular call needed to be split into 17 different trades to become filled. The total cost received by the writing party (or parties) was $25.8K, with a price of $760.0 per contract. There were 161 open contracts at this strike prior to today, and today 657 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

GILD

Hims & Hers Health, Inc. Class A Common Stock

HIMS

SMLR

VRNA

4 Health Care Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Financials sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TIGR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$9.00</td>
<td>$219.1K</td>
<td>1.2K</td>
<td>94.1K</td>
</tr>
<tr>
<td>HOOD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/27/25</td>
<td>$85.00</td>
<td>$40.3K</td>
<td>386</td>
<td>3.9K</td>
</tr>
<tr>
<td>C</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$77.50</td>
<td>$126.0K</td>
<td>15.4K</td>
<td>2.2K</td>
</tr>
<tr>
<td>RKT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$21.20</td>
<td>$48.8K</td>
<td>4.1K</td>
<td>660</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding TIGR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>), we observe a call option trade with bullish sentiment. It expires in 205 day(s) on January 16, 2026. Parties traded 891 contract(s) at a $9.00 strike. The total cost received by the writing party (or parties) was $219.1K, with a price of $246.0 per contract. There were 1204 open contracts at this strike prior to today, and today 94144 contract(s) were bought and sold. 
• For HOOD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), we notice a put option trade that happens to be bearish, expiring in 2 day(s) on June 27, 2025. This event was a transfer of 120 contract(s) at a $85.00 strike. The total cost received by the writing party (or parties) was $40.3K, with a price of $336.0 per contract. There were 386 open contracts at this strike prior to today, and today 3986 contract(s) were bought and sold. 
• For C (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), we notice a call option trade that happens to be bullish, expiring in 23 day(s) on July 18, 2025. This event was a transfer of 225 contract(s) at a $77.50 strike. The total cost received by the writing party (or parties) was $126.0K, with a price of $560.0 per contract. There were 15469 open contracts at this strike prior to today, and today 2260 contract(s) were bought and sold. 
• For RKT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>), we notice a call option sweep that happens to be bullish, expiring in 205 day(s) on January 16, 2026. This event was a transfer of 660 contract(s) at a $21.20 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $48.8K, with a price of $74.0 per contract. There were 4109 open contracts at this strike prior to today, and today 660 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

HOOD

TIGR

4 Financials Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/27/25</td>
<td>$152.50</td>
<td>$30.6K</td>
<td>51.6K</td>
<td>380.2K</td>
</tr>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/03/25</td>
<td>$202.50</td>
<td>$44.2K</td>
<td>5.9K</td>
<td>12.8K</td>
</tr>
<tr>
<td>AMD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/27/25</td>
<td>$142.00</td>
<td>$32.2K</td>
<td>519</td>
<td>11.9K</td>
</tr>
<tr>
<td>ARM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$100.00</td>
<td>$43.9K</td>
<td>11.0K</td>
<td>1.8K</td>
</tr>
<tr>
<td>TWLO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$115.00</td>
<td>$71.6K</td>
<td>5.3K</td>
<td>1.0K</td>
</tr>
<tr>
<td>MU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$120.00</td>
<td>$515.0K</td>
<td>23.4K</td>
<td>748</td>
</tr>
<tr>
<td>MSTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$380.00</td>
<td>$26.9K</td>
<td>1.2K</td>
<td>168</td>
</tr>
<tr>
<td>AMAT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/11/25</td>
<td>$180.00</td>
<td>$66.4K</td>
<td>234</td>
<td>161</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• For NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we notice a call option sweep that happens to be bullish, expiring in 2 day(s) on June 27, 2025. This event was a transfer of 120 contract(s) at a $152.50 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $30.6K, with a price of $255.0 per contract. There were 51630 open contracts at this strike prior to today, and today 380266 contract(s) were bought and sold. 
• For AAPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), we notice a call option sweep that happens to be bullish, expiring in 8 day(s) on July 3, 2025. This event was a transfer of 157 contract(s) at a $202.50 strike. This particular call needed to be split into 31 different trades to become filled. The total cost received by the writing party (or parties) was $44.2K, with a price of $282.0 per contract. There were 5926 open contracts at this strike prior to today, and today 12801 contract(s) were bought and sold. 
• For AMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), we notice a put option sweep that happens to be bullish, expiring in 2 day(s) on June 27, 2025. This event was a transfer of 200 contract(s) at a $142.00 strike. This particular put needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $32.2K, with a price of $161.0 per contract. There were 519 open contracts at this strike prior to today, and today 11920 contract(s) were bought and sold. 
• Regarding ARM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>), we observe a put option sweep with bullish sentiment. It expires in 205 day(s) on January 16, 2026. Parties traded 112 contract(s) at a $100.00 strike. This particular put needed to be split into 9 different trades to become filled. The total cost received by the writing party (or parties) was $43.9K, with a price of $385.0 per contract. There were 11043 open contracts at this strike prior to today, and today 1801 contract(s) were bought and sold. 
• For TWLO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>), we notice a call option sweep that happens to be neutral, expiring in 23 day(s) on July 18, 2025. This event was a transfer of 90 contract(s) at a $115.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $71.6K, with a price of $795.0 per contract. There were 5370 open contracts at this strike prior to today, and today 1045 contract(s) were bought and sold. 
• Regarding MU (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), we observe a call option sweep with bullish sentiment. It expires in 23 day(s) on July 18, 2025. Parties traded 500 contract(s) at a $120.00 strike. This particular call needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $515.0K, with a price of $1030.0 per contract. There were 23411 open contracts at this strike prior to today, and today 748 contract(s) were bought and sold. 
• For MSTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), we notice a call option trade that happens to be neutral, expiring in 51 day(s) on August 15, 2025. This event was a transfer of 8 contract(s) at a $380.00 strike. The total cost received by the writing party (or parties) was $26.9K, with a price of $3365.0 per contract. There were 1257 open contracts at this strike prior to today, and today 168 contract(s) were bought and sold. 
• Regarding AMAT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>), we observe a call option trade with bullish sentiment. It expires in 16 day(s) on July 11, 2025. Parties traded 109 contract(s) at a $180.00 strike. The total cost received by the writing party (or parties) was $66.4K, with a price of $610.0 per contract. There were 234 open contracts at this strike prior to today, and today 161 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAPL

AMAT

MSTR

NVDA

TWLO

8 Information Technology Stocks With Whale Alerts In Today's Session

CAPR

Capricor Therapeutics shares are trading higher. Jones Trading maintained a Buy rating on the stock.

Macquarie analyst Steve Koenig maintains GitLab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) with a Outperform and maintains $75 price target.

GTLB

Macquarie Maintains Outperform on GitLab, Maintains $75 Price Target

Signify

Comments

Signify

ニュース

最新ニュース Signify (OTC:PHPPY) 株価情報

ニュース

パートナーシップ

ベンジンガ・グローバル